Literature DB >> 6287932

Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits.

R C Johnson, R F Bey, S J Wolgamot.   

Abstract

The activity of ceftriaxone, a newly developed cephalosporin, against early cutaneous infections with Treponema pallidum in rabbits was compared with that of equimolar doses of penicillin G. Activity was related to the time required for cutaneous lesions to become dark-field negative, serological response, and the disappearance of T. pallidum from the popliteal lymph nodes. Both antibiotics were very effective in the treatment of syphilis in this animal model. The 50% curative dose for penicillin G was 0.8 mumol/kg (0.29 mg or 480 U/kg) and for ceftriaxone, it was 1.45 mumol/kg (0.96 mg/kg). Overall, ceftriaxone was slightly less effective than penicillin G was. Transmission and scanning electron microscopy studies of testicular aspirates obtained from rabbits treated with ceftriaxone revealed alterations in the treponeme surface which apparently resulted in changes in cell permeability and morphology.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287932      PMCID: PMC182057          DOI: 10.1128/AAC.21.6.984

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  EFFECT OF ACTINOSPECTACIN IN EXPERIMENTAL SYPHILIS IN THE RABBIT. I. EARLY LESION SYPHILIS.

Authors:  J W CLARK; A R YOBS
Journal:  Br J Vener Dis       Date:  1963-09

Review 2.  The spirochetes.

Authors:  R C Johnson
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

3.  Diffusion of ceftriaxone (Ro 13-9004/001) in the cerebrospinal fluid. Comparison with other beta-lactam antibiotics in dogs with healthy meninges and in dogs with experimental meningitis.

Authors:  B Marchou; M Armengaud
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

4.  Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.

Authors:  K Stoeckel
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

5.  Helix handedness of Leptospira interrogans as determined by scanning electron microscopy.

Authors:  O Carleton; N W Charon; P Allender; S O'Brien
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

6.  One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin. A dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.

Authors:  A Eichmann; G Weidmann; L Havas
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

7.  Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

8.  Electron microscope study of DNA-containing plasms. II. Vegetative and mature phage DNA as compared with normal bacterial nucleoids in different physiological states.

Authors:  E KELLENBERGER; A RYTER; J SECHAUD
Journal:  J Biophys Biochem Cytol       Date:  1958-11-25
  8 in total
  16 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Neurosyphilis: A Current Review.

Authors:  Judith A O'donnell; Christopher L Emery
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

3.  In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain).

Authors:  S J Norris; D G Edmondson
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.

Authors:  C A Dixon; J B Bittiner; M Shahidullah; R C Slack; M Z Sulaiman
Journal:  Genitourin Med       Date:  1986-04

5.  Susceptibility to antimicrobials of Neisseria gonorrhoeae isolated in Singapore: implications on the need for more effective treatment regimens and control strategies.

Authors:  E H Sng; A L Lim; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-12

Review 6.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 7.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 8.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Single-dose ceftriaxone for chancroid.

Authors:  M I Bowmer; H Nsanze; L J D'Costa; J Dylewski; L Fransen; P Piot; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.